VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 36 filers reported holding VINCERX PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $135,090 | +17.3% | 114,000 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $115,140 | -85.3% | 114,000 | -81.1% | 0.00% | -85.7% |
| Q2 2023 | $782,138 | +19.2% | 601,645 | -4.6% | 0.01% | +16.7% |
| Q1 2023 | $656,158 | +12.2% | 630,922 | +10.1% | 0.01% | +20.0% |
| Q4 2022 | $584,711 | -11.8% | 573,246 | +19.3% | 0.01% | -16.7% |
| Q3 2022 | $663,000 | +71.3% | 480,646 | +63.8% | 0.01% | +50.0% |
| Q2 2022 | $387,000 | -63.5% | 293,401 | +10.8% | 0.00% | -60.0% |
| Q1 2022 | $1,060,000 | -64.4% | 264,877 | -9.4% | 0.01% | -63.0% |
| Q4 2021 | $2,980,000 | -31.9% | 292,477 | +8.0% | 0.03% | -40.0% |
| Q3 2021 | $4,379,000 | +54.4% | 270,822 | +24.0% | 0.04% | +50.0% |
| Q2 2021 | $2,836,000 | -30.7% | 218,367 | +3.1% | 0.03% | -40.0% |
| Q1 2021 | $4,090,000 | +154.4% | 211,867 | +175.4% | 0.05% | +127.3% |
| Q4 2020 | $1,608,000 | – | 76,937 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 1,492,771 | $1,552,482 | 0.51% |
| SAGE RHINO CAPITAL LLC | 1,686,937 | $1,754,414 | 0.51% |
| SABBY MANAGEMENT, LLC | 353,400 | $367,536 | 0.32% |
| Tejara Capital Ltd | 290,882 | $302,517 | 0.16% |
| Long Focus Capital Management, LLC | 1,414,951 | $1,471,549 | 0.08% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $400,400 | 0.08% |
| Sio Capital Management, LLC | 102,049 | $106,131 | 0.05% |
| Rock Springs Capital Management LP | 891,719 | $927,388 | 0.02% |
| Clearline Capital LP | 98,916 | $102,872 | 0.02% |
| TANG CAPITAL MANAGEMENT LLC | 101,762 | $105,832 | 0.02% |